N
6.76
0.19 (2.89%)
Penutupan Terdahulu | 6.57 |
Buka | 6.49 |
Jumlah Dagangan | 2,102,044 |
Purata Dagangan (3B) | 2,067,453 |
Modal Pasaran | 395,608,064 |
Harga / Jualan (P/S) | 38.45 |
Harga / Buku (P/B) | 2.52 |
Julat 52 Minggu | |
Tarikh Pendapatan | 21 Nov 2024 |
Margin Operasi (TTM) | -535.86% |
EPS Cair (TTM) | -0.860 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 4.50% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 4.41% |
Nisbah Semasa (MRQ) | 5.16 |
Aliran Tunai Operasi (OCF TTM) | -41.93 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -35.33 M |
Pulangan Atas Aset (ROA TTM) | -17.15% |
Pulangan Atas Ekuiti (ROE TTM) | -31.17% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Bercampur | Bercampur |
Medical Devices (Global) | Bercampur | Bercampur | |
Stok | NANO-X IMAGING LTD | Menurun | Menurun |
AISkor Stockmoo
0.8
Konsensus Penganalisis | -0.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | 5.0 |
Osilator Teknikal | 0.5 |
Purata | 0.75 |
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 8.99% |
% Dimiliki oleh Institusi | 18.67% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Griffin Asset Management, Inc. | 30 Sep 2024 | 197,389 |
Johnson & Johnson | 30 Sep 2024 | 158,852 |
Julat 52 Minggu | ||
Median | 12.00 (77.52%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Cantor Fitzgerald | 06 Dec 2024 | 12.00 (77.51%) | Beli | 7.97 |
26 Nov 2024 | 11.00 (62.72%) | Beli | 6.07 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
05 Dec 2024 | Pengumuman | Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication |
21 Nov 2024 | Pengumuman | Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update |
11 Nov 2024 | Pengumuman | Nanox to Report Third Quarter and Financial Results on November 21, 2024 |
31 Oct 2024 | Pengumuman | Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2024 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |